Volume 14, Issue 4 (Jul-Aug 2020)                   mljgoums 2020, 14(4): 7-12 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
ghaemi E A, azadi F, javid N, bagheri H. Presence of Silver Resistance Genes is not associated with Minimum Inhibitory Concentration of Silver Nanoparticles against Staphylococcus aureus and Escherichia coli. mljgoums 2020; 14 (4) :7-12
URL: http://mlj.goums.ac.ir/article-1-1260-en.html
Presence of Silver Resistance Genes is not associated with Minimum Inhibitory Concentration of Silver Nanoparticles against Staphylococcus aureus and Escherichia coli
Ezzat allah Ghaemi 1, Fahimeh Azadi2 , Naeme Javid2 , Hanieh Bagheri2
1- Laboratory Science Research Center, Golestan University of Medical Sciences, Gorgan, Golestan, Iran , eghaemi@yahoo.com
2- Department of Microbiology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Golestan, Iran
Abstract:   (2139 Views)
Background and objectives: Drug resistance in Staphylococcus aureus and Escherichia coli, as severe pathogenic bacteria, has become a health challenge. However, nanoparticles have been introduced as effective candidates for their eradication. In this study, we investigated presence of genes involved in conferring resistance to silver nanoparticles in S. aureus and E. coli isolates and evaluated its association with minimal inhibitory concentration (MIC) of the nanoparticles against these isolates.
Methods: The MIC of silver nanoparticles against 121 clinical isolates of E. coli and 183 S. aureus isolates was assessed by broth microdilution assay. Presence and expression of the silver resistance genes (silE, silR/S) in the isolates were investigated by PCR and real-time PCR, respectively.
Results: The silE gene was found in three (1.6%) S. aureus and four (3%) E. coli isolates. MIC of silver nanoparticles against S. aureus isolates with the silE gene was 1, 2 and 8 µg/ml. Moreover, the MIC of the nanoparticles against silE-positive E. coli isolates was 16 μg/ml in three cases and 8 μg/ml in one case. None of the S. aureus isolates contained the silR/S gene, but presence of both silE and silR/S was confirmed in two E. coli isolates. Real-time PCR showed no sil expression in the isolates containing the resistance genes.
Conclusion: The frequency of the silver resistance genes among S. aureus and E. coli isolates is very low. There is no relationship between presence of the resistance genes and the MIC value of silver nanoparticles.
Keywords: Staphylococcus aureus, Escherichia coli, Silver particles, MIC
Full-Text [PDF 661 kb]   (565 Downloads)    
Research Article: Original Paper | Subject: Microbiology
Received: 2019/10/23 | Accepted: 2019/12/11 | Published: 2020/06/30 | ePublished: 2020/06/30
References
1. Franci G, Falanga A, Galdiero S, Palomba L, Rai M, Morelli G, Galdiero M. Silver nanoparticles as potential antibacterial agents. Molecules. 2015; 20(5): 8856-74. [DOI:10.3390/molecules20058856] [PubMed] [Google Scholar]
2. Namasivayam SKR, Preethi M, Bharani ARS, Robin G, Latha B. Biofilm inhibitory effect of silver nanoparticles coated catheter against Staphylococcus aureus and evaluation of its synergistic effects with antibiotics. Int J Biol Pharm Res. 2012; 3(2):259-65. [Google Scholar]
3. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnology advances. 2009; 27(1): 76-83. https://doi.org/10.1016/j.biotechadv.2008.09.002 [DOI:10.1016/j.biotechadv.2008.09.002.] [PubMed] [Google Scholar]
4. Lara HH, Garza-TreviñoEN, Ixtepan-Turrent L, Singh DK. Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds. Journal of nanobiotechnology. 2011; 9(1): 30. https://doi.org/10.1186/1477-3155-9-30 [DOI:10.1186/1477-3155-9-30.] [PubMed] [Google Scholar]
5. Lara HH, Garza-TreviñoEN, Ixtepan-Turrent L, Singh DK. Synergistic effects between silver nanoparticles and antibiotics and the mechanisms involved. Journal of medical microbiology. 2012; 61(12): 1719-26. doi: 10.1099/jmm.0.047100-0. [DOI:10.1099/jmm.0.047100-0] [PubMed] [Google Scholar]
6. Finley P, Peterson A, Huckfeldt R. The prevalence of phenotypic silver resistance in clinical isolates. Wounds: a compendium of clinical research and practice. 2013; 25(4): 84-8. [PubMed] [Google Scholar]
7. Chopra I. The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern? .Journal of antimicrobial chemotherapy. 2007; 59(4): 587-90. https://doi.org/10.1093/jac/dkm006 [DOI:10.1093/jac/dkm006.] [PubMed] [Google Scholar]
8. Percival SL, Bowler P, Russell D. Bacterial resistance to silver in wound care. Journal of hospital infection. 2005; 60(1): 1-7. https://doi.org/10.1016/j.jhin.2004.11.014 [DOI:10.1016/j.jhin.2004.11.014.] [PubMed] [Google Scholar]
9. Silver S. Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS microbiology reviews. 2003; 27(2-3): 341-53. https://doi.org/10.1016/S0168-6445(03)00047-0 [DOI:10.1016/S0168-6445(03)00047-0.] [PubMed] [Google Scholar]
10. Durán N , Durán M , Bispo de Jesus M, Seabra A , Fávaro W, Nakazato G.Silver nanoparticles: a new view on mechanistic aspects on antimicrobial activity . Nanomedicine: Nanotechnology, Biology and Medicine. 2016; 12(3): 789-99. https://doi.org/10.1016/j.nano.2015.11.016 [DOI:10.1016/j.nano.2015.11.016.] [PubMed] [Google Scholar]
11. Woods E, Cochrane C, Percival S. Prevalence of silver resistance genes in bacteria isolated from human and horse wounds. Vet microbial. 2009; 138(3-4): 325-9. https://doi.org/10.1016/j.vetmic.2009.03.023 [DOI:10.1016/j.vetmic.2009.03.023.] [PubMed] [Google Scholar]
12. Azadi F, Jamali A, Baei B , Bazouri M, Shakeri F, Ghaemi EA.Presence of Silver Resistance Genes is not associated with Minimum Inhibitory Concentration of Silver Nanoparticles against Staphylococcus aureus and Escherichia coli . J Gorgan Univ Med Sci. 2016; 18(3): 86-91. [Google Scholar]
13. Taherirad A, Jahanbakhsh R, Shakeri F, Anvary S, Ghaemi EA. Staphylococcal cassette chromosome mec types among methicillin-resistant Staphylococcus aureus in northern Iran. Jundishapur J Microbiol. 2016; 9(8): e33933. [DOI:10.5812/jjm.33933] [PubMed] [Google Scholar]
14. Shakeri F, Shojai A, Golalipour M, RahimiAlang S, Vaez H, Ghaemi EA. Spa Diversity among MRSA and MSSA Strains of Staphylococcus aureus in North of Iran. International journal of microbiology. 2010; Article ID 351397. doi:10.1155/2010/351397. [DOI:10.1155/2010/351397] [PubMed] [Google Scholar]
15. Hosseini F, Mirzaii M, Salehi M. The Study of Cross-Resistance Between Silver and Antibiotics in Isolated Bacterial Strains From A Burns Unit. Advances in Environmental Biology. 2011; 5(10): 3164-3172.
16. Sütterlin S. Aspects of bacterial resistance to silver: ActaUniversitatisUpsaliensis. 2015. [Google Scholar]
17. Loh JV, Percival SL, Woods EJ, Williams NJ, Cochrane CA. Silver resistance in MRSA isolated from wound and nasal sources in humans and animals. Int Wound J. 2009; 6(1): 32-8. https://doi.org/10.1111/j.1742-481X.2008.00563.x [DOI:10.1111/j.1742-481X.2008.00563.x.] [PubMed] [Google Scholar]
18. Sutterlin S, Dahlo M, Tellgren-Roth C, Schaal W, Melhus A. High frequency of silver resistance genes in invasive isolates of Enterobacter and Klebsiella species. J Hosp Infect. 2017; 96(3): 256-61. [DOI:10.1016/j.jhin.2017.04.017] [PubMed] [Google Scholar]
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2007 All Rights Reserved | Medical Laboratory Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.